Recovery of recombinant factor IX determined in clinical practice-Reference-Cited by-同舟云学术

Recovery of recombinant factor IX determined in clinical practice

Published:2009-05 Issue:3 Volume:15 Page:840-842
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

MARTORELL M.,ALTISENT C.,PARRA R.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2009.02000.x/fullpdf

Reference5 articles.

1. Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates;Roth;Blood,2001

2. Recombinant factor IX recovery and inhibitor safety: a Canadian post-licensure surveillance study;Poon;Thromb Haemost,2002

3. Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis;Björkman;Haemophilia,2001

4. 4 Lee M , Morfini M , Schulman S , Ingerslev J , Factor VIII/FIX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis. The Design and Analysis of Pharmacokinetic Studies of Coagulation Factors. Available at: http://www.med.unc.edu/isth/ (last accessed on 28 September 2008).

5. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting;Björkman;Haemophilia,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of plasma-derived and recombinant factor IX - implications for prophylaxis and on-demand therapy;Haemophilia;2013-06-20

2. A commentary on the differences in pharmacokinetics between recombinant and plasma-derived factor IX and their implications for dosing;Haemophilia;2011-02-07

3. Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy;BLOOD TRANSFUS-ITALY;2011

4. Recombinant Factor IX for Clinical and Research Use;Seminars in Thrombosis and Hemostasis;2010-07